Evidence map›Paper›PMID 33664880›Full record

ArticleJournal of arrhythmia2021

Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation.

Naoaki Onishi, Shokan Kyo, Maki Oi, Toshikazu Jinnai, Maiko Kuroda, Yukiko Shimizu, Sari Imamura, Takeshi Harita, Suguru Nishiuchi, Koji Hanazawa and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of arrhythmia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Catheter ablation for non-paroxysmal atrial fibrillation. A review.Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia · 2024
    Review
  5. Anxiety and Depressive Symptoms, Frailty and Quality of Life in Atrial Fibrillation.International journal of environmental research and public health · 2023
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Naoaki OnishiDivision of Cardiology Tenri Hospital Tenri Japan.ORCID https://orcid.org/0000-0002-0918-0285
Shokan KyoJapanese Red Cross Otsu Hospital Otsu Japan.
Maki OiJapanese Red Cross Otsu Hospital Otsu Japan.ORCID https://orcid.org/0000-0003-4342-2118
Toshikazu JinnaiJapanese Red Cross Otsu Hospital Otsu Japan.
Maiko KurodaDivision of Cardiology Tenri Hospital Tenri Japan.
Yukiko ShimizuDivision of Cardiology Tenri Hospital Tenri Japan.ORCID https://orcid.org/0000-0003-0616-894X
Sari ImamuraDivision of Cardiology Tenri Hospital Tenri Japan.
Takeshi HaritaDivision of Cardiology Tenri Hospital Tenri Japan.
Suguru NishiuchiDivision of Cardiology Tenri Hospital Tenri Japan.
Koji HanazawaDivision of Cardiology Tenri Hospital Tenri Japan.
Toshihiro TamuraDivision of Cardiology Tenri Hospital Tenri Japan.
Chisato IzumiDivision of Cardiology Tenri Hospital Tenri Japan.
Yoshihisa NakagawaDivision of Cardiology Tenri Hospital Tenri Japan.
Kazuaki KaitaniDivision of Cardiology Tenri Hospital Tenri Japan.
Tenri Hospital · JPOtsu Red Cross Hospital · JPShiga University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCatheter ablation (CA) for atrial fibrillation (AF) is widely performed. However, the indication for CA in patients with asymptomatic persistent AF is still controversial.

methodsAmong 259 consecutive patients who were hospitalized for initial CA of AF, a total of 45 patients who had asymptomatic persistent AF were retrospectively analyzed. Quality of life (QOL) before and 1 year after CA was evaluated, and changes in the cardiac function over 5 years after CA were also examined. QOL was assessed using the AF QOL questionnaire (AFQLQ) developed by the Japanese Heart Rhythm Society. In addition, cardiac function was assessed by measuring the plasma B-type natriuretic peptide (BNP) level, left ventricular ejection fraction (LVEF), left atrial diameter (LAD) with transthoracic echocardiogram, and left atrial (LA) volume with computed tomography (CT).

resultsThe AFQLQ significantly improved after CA in terms of "symptom frequency" and "activity limits and mental anxiety." The plasma BNP level, LVEF, and LAD significantly improved in the first 3 months after the first CA, with no significant changes thereafter (from 149.0 pg/dL [95% confidence intervals {CI}, 114.5-183.5 pg/dL] to 49.8 pg/dL [95% CI, 26.5-70.1],

conclusionImprovement in the QOL and cardiac function after CA of asymptomatic persistent AF was revealed. Asymptomatic persistent AF should be appropriately treated by CA.

Indexed as

atrial fibrillationB‐type natriuretic peptidecatheter ablationquality of lifereverse remodeling

Identifiers

PMID33664880
PMCPMC7896458
OpenAlexW3111874239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.